Biote reports second quarter 2025 financial results

Irving, texas--(business wire)--biote (nasdaq: btmd), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the second quarter ended june 30, 2025. “consistent with our action plan to drive structural and cultural change, biote initiated an organizational restructuring in early may designed to strengthen our business and position us for increased and sustainable profitable.
BTMD Ratings Summary
BTMD Quant Ranking